title: Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis.
abstract: Considering the high frequency of bleeding complications following fibrinolytic treatment, caudal blockade could be used in association with lower doses of tissue plasminogen activator as a possible new therapeutic approach in management of arterial thrombosis in neonates.
authors.forename: M P
authors.initials: MP
authors.lastname: De Carolis
authors.forename: C
authors.initials: C
authors.lastname: Romagnoli
authors.forename: A
authors.initials: A
authors.lastname: Gasbarrini
authors.forename: G
authors.initials: G
authors.lastname: de Francisci
authors.forename: F
authors.initials: F
authors.lastname: Piersigilli
authors.forename: F
authors.initials: F
authors.lastname: Cremonini
authors.forename: M
authors.initials: M
authors.lastname: Cittadino
authors.forename: P
authors.initials: P
authors.lastname: Pola
authors.forename: G
authors.initials: G
authors.lastname: Tortorolo
mesh_terms: D000763:Anesthesia, Caudal; D002404:Catheterization / Q000009:adverse effects*; D002543:Cerebral Hemorrhage / Q000209:etiology; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014469:Umbilical Arteries
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator